Skip to main content

Table 1 Group comparisons

From: Natural history of conjugated bilirubin trajectory in neonates following parenteral nutrition cessation

 

Up group, n = 27

Down group, n = 16

 

Gender (M)

20 (74%)

10 (63%)

p = 0.638

Gestational age

27.26 ± 3.59

27.25 ± 4.60

p = 0.637

Birth weight, g

992 ± 613

984 ± 663

p = 0.315

Ethnicity (n)

   

 Caucasian

10

5

p = 0.185

 African American

11

3

 

 Hispanic

3

6

 

 Asian

1

0

 

 Unknown

2

2

 

Length of stay, days

129.52 ± 67.67

141.31 ± 58.11

p = 0.499

Duration of PN, days

53.96

49.63

p = 0.421

Intrauterine growth retardation (IUGR)

2

1

p = 1.00

Age at EN initiation, days

11.15 ± 13.80

24.13 ± 22.53

p = 0.037

Type of EN (n)

  

p = 0.573

 BM

8

3

 

 Standard formula

13

11

 

 Protein hydrosylate

2

0

 

 Amino Acid

4

2

 

Route of feeding administration (n)

  

p = 0.196

 PO/bolus

25

13

 

 Continuous

1

0

 

 Combination

1

3

 

Ursodiol use (n)

19

8

p = 0.182

 Start & stop before PN cessation

   

 Start before, stop after PN cessation

9

2

 

 Start and stop after PN cessation

13

4

 

Sepsis (n)

14

8

p = 0.578

 Occurred before PN cessation

13

5

p = 0.117

 Occurred after PN cessation

1

2

 

 Occurred before and after PN cessation

0

1

 

 Gram negative sepsis

5

3

p = 0.642

  Occurred before PN cessation

5

2

p = 0.375

  Occurred after PN cessation

0

1

 

Rate of normalization (CB < 2 mg/dL)

16

12

p = 0.295